Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes

Claire M. Connell,S Raby,I Beh,Thomas R. Flint,Edward Williams,Douglas T. Fearon,Duncan I. Jodrell,Tobias Janowitz

Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes

2017

Claire M. Connell
S Raby
I Beh
Thomas R. Flint
Edward Williams
Douglas T. Fearon
Duncan I. Jodrell
Tobias Janowitz

This work was supported by the Wellcome Trust Translational Medicine and Therapeutics Programme [RJAG/076 to TJ], Cancer Research UK and the Cambridge Translational Medicine and Therapeutics Academic Clinical Fellowship Programme (to CMC).

Keywords:

Translational medicine
Cancer immunotherapy
Medicine
Clinical trial
Pathology
Immunotherapy
Cancer
Glucocorticoid therapy
Immunosuppression
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations